Healthcare
PR Agency.

100+
markets for healthcare PR
36
years in regulated industry communications
4
audiences: clinical, regulatory, payer, commercial

Healthcare earns trust before it earns adoption. The clinicians, payers, regulators and patients who decide market access respond to evidence, credibility and peer endorsement, not marketing claims. Healthcare PR is the discipline of getting that evidence heard, accurately, in every market.

01
Sector overview

Healthcare communications,
built on evidence and trust.

GlobalCom is a healthcare PR agency with in-market teams across more than 100 countries. Healthcare is a broad field: pharmaceutical and biotech companies, medical device and diagnostics manufacturers, digital health and health IT, hospitals and health systems, and the life sciences companies that supply them. Each answers to clinicians, regulators, payers and patients, audiences that respond to evidence and credibility rather than advertising.

A specialist healthcare PR firm knows which clinical and trade titles carry weight with each audience, how to communicate a regulatory or clinical milestone accurately, and how to build the peer credibility that market access depends on. GlobalCom has run communications for companies across pharma, biotech, medtech, diagnostics, digital health and life sciences, in every major healthcare market.

Market access in healthcare is not won through advertising. It is won through clinical evidence, regulatory credibility and peer recommendation, all of which have communications components that we help our clients manage.

For device, diagnostics and digital health technology specifically, see our dedicated HealthTech & MedTech PR page.

Three areas of sector-specific focus.

01 · Core

Healthcare & Pharma Media Relations

A specialist healthcare PR firm earns accurate, credible coverage in the publications that clinicians, pharmacists, payers and health system leaders trust, from clinical and pharma trade press to healthcare business media.

  • Pharmaceutical and biotech trade press
  • Medical device and diagnostics media
  • Digital health and health IT publications
  • Hospital, provider and health system media
  • Health policy and payer publications
  • Healthcare investor and sector finance press
02 · Core

Regulatory, Clinical & Data Communications

Communications support for the milestones that define healthcare market access: approvals, clinical results, reimbursement and safety. Each requires carefully structured communications to clinical, regulatory and payer audiences.

  • Regulatory approval and label announcement strategy
  • Clinical trial and real-world evidence communications
  • Reimbursement, HTA and market-access communications
  • Safety, recall and issues communications
  • Medical congress and scientific communications
  • Patient data privacy and trust communications
03 · Core

Patient, Provider & Public Health Communications

Communications that build trust with patients, clinicians and the public health community, accurate, compassionate and compliant with the rules for healthcare communications in each market.

  • Patient community and advocacy engagement
  • Clinician and key opinion leader relations
  • Public health and awareness campaigns
  • Health literacy and accessible communications
  • Condition-specific media relations
  • Provider and health system reputation
03 · How it works

Clinical audiences.
Commercial outcomes.

01

Landscape and stakeholder mapping

We map the regulatory pathway, the clinical community, the payer environment and the media landscape in each target market. Healthcare systems vary enormously; what works in Germany does not automatically work in the UK or the US.

02

Audience-specific messaging

Clinical, regulatory, payer and commercial audiences need fundamentally different communications, though the underlying evidence base is the same. We build the messaging architecture that serves all of them without contradiction.

03

In-market delivery

Healthcare-experienced consultants in each target market handle clinical media relations, regulatory communications and commercial PR, in the local language, with knowledge of the local healthcare system.

04

Measurement and reporting

Monthly reporting on clinical and business media coverage, regulatory communications outcomes, key opinion leader engagement and share of voice in the publications that matter in each market.

04 · The delivery model

Central strategy.
Local expertise.

Healthcare market access is a country-by-country process. An approval may open a region, but reimbursement, procurement and clinical adoption are national. NHS procurement works differently from Krankenhaus procurement in Germany, and hospital group purchasing in the US is unlike either. Communications programmes that do not account for this will underperform.

GlobalCom coordinates healthcare communications as a single global programme with country-level precision. The senior lead owns the strategy. In-market specialists with healthcare system knowledge execute locally, so the evidence is communicated accurately to the right audience in every market.

  • Communications accurate to regulatory requirements in each market
  • Clinical, payer and commercial messaging held consistently
  • Healthcare trade and business media in all major markets
  • Patient and public health communications compliant with local standards
100+
Markets for healthcare, pharma and medtech PR
4
Audience layers: clinical, regulatory, payer, commercial
36
Years in regulated industry communications
05
Your sector specialist

Healthcare communications specialist.

Richard Merrin
Richard Merrin
Healthcare & Health Technology

Over 25 years of B2B technology and reputation communications experience, with particular specialist depth in digital health, medtech and health technology. Works with healthcare innovators across the full spectrum, from early-stage digital health companies to established medical device and life sciences businesses, across areas including AI in healthcare, remote diagnostics, e-health platforms and connected health. Combines enterprise communications expertise with deep knowledge of the regulatory and stakeholder environment that healthcare organisations navigate.

Healthcare PR, answered.

What does a healthcare PR agency do?

A healthcare PR agency earns credible coverage and builds reputation for healthcare organisations with the clinicians, regulators, payers and patients who decide market access. GlobalCom runs these programmes across more than 100 markets through healthcare-specialist consultants and one senior lead.

Which parts of healthcare do you cover?

Pharmaceuticals and biotech, medical devices and diagnostics, digital health and health IT, hospitals and health systems, and the life sciences companies that supply them. For device and technology specifically, we also run a dedicated HealthTech and MedTech practice.

How do you handle regulated healthcare claims?

Every clinical and regulatory claim is checked against the evidence and the rules in each market. Accurate, substantiated messaging is what protects both coverage and reputation in a field where regulators and journalists scrutinise every statement.

Can you support a product approval or launch?

Yes. We structure communications around the milestones that matter, from clinical trial results and regulatory approvals to reimbursement and launch, and coordinate them across every target market from one plan.

Which markets can you run healthcare PR in?

More than 100 markets across Europe, the Americas, Asia Pacific, the Middle East and Africa, with local consultants who know the clinical, trade and business media and the healthcare system in each one.

How is GlobalCom different from other healthcare PR firms?

You get one senior lead and one consolidated report, with healthcare-specialist teams delivering in every market rather than a single agency working at a distance. It combines the local depth of a network with the accountability of a single agency.

Ready to build your healthcare communications programme?

Tell us your regulatory pathway, your target markets and your clinical evidence. We will design the programme.